These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24717411)

  • 1. Single and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum.
    Chauhan H; Killinger BA; Miller CV; Moszczynska A
    Int J Mol Sci; 2014 Apr; 15(4):5884-906. PubMed ID: 24717411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.
    Hadlock GC; Baucum AJ; King JL; Horner KA; Cook GA; Gibb JW; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2009 Apr; 329(1):169-74. PubMed ID: 19141713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activation.
    Hadlock GC; Chu PW; Walters ET; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2010 Oct; 335(1):207-12. PubMed ID: 20622144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity.
    Liu B; Traini R; Killinger B; Schneider B; Moszczynska A
    Exp Neurol; 2013 Sep; 247():359-72. PubMed ID: 23313192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and reversible effects of methamphetamine on dopamine transporters.
    Fleckenstein AE; Metzger RR; Wilkins DG; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1997 Aug; 282(2):834-8. PubMed ID: 9262348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
    Killinger BA; Moszczynska A
    J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.
    McFadden LM; Hadlock GC; Allen SC; Vieira-Brock PL; Stout KA; Ellis JD; Hoonakker AJ; Andrenyak DM; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2012 Feb; 340(2):295-303. PubMed ID: 22034657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism.
    Baucum AJ; Rau KS; Riddle EL; Hanson GR; Fleckenstein AE
    J Neurosci; 2004 Mar; 24(13):3436-43. PubMed ID: 15056723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity.
    Gross NB; Duncker PC; Marshall JF
    Synapse; 2011 Nov; 65(11):1144-55. PubMed ID: 21584865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalization.
    German CL; Hanson GR; Fleckenstein AE
    J Neurochem; 2012 Oct; 123(2):288-97. PubMed ID: 22804716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.
    Sandoval V; Riddle EL; Ugarte YV; Hanson GR; Fleckenstein AE
    J Neurosci; 2001 Feb; 21(4):1413-9. PubMed ID: 11160413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct dose-dependent effects of methamphetamine on real-time dopamine transmission in the rat nucleus accumbens and behaviors.
    Bhimani RV; Vik M; Wakabayashi KT; Szalkowski C; Bass CE; Park J
    J Neurochem; 2021 Aug; 158(4):865-879. PubMed ID: 34265079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms.
    Cervinski MA; Foster JD; Vaughan RA
    J Biol Chem; 2005 Dec; 280(49):40442-9. PubMed ID: 16204245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D3 autoreceptor inhibition enhances cocaine potency at the dopamine transporter.
    McGinnis MM; Siciliano CA; Jones SR
    J Neurochem; 2016 Sep; 138(6):821-9. PubMed ID: 27393374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia.
    Metzger RR; Haughey HM; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1077-85. PubMed ID: 11082443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia.
    Haughey HM; Fleckenstein AE; Metzger RR; Hanson GR
    J Neurochem; 2000 Oct; 75(4):1608-17. PubMed ID: 10987842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine.
    Granado N; Ares-Santos S; O'Shea E; Vicario-Abejón C; Colado MI; Moratalla R
    Neurotox Res; 2010 Jul; 18(1):48-58. PubMed ID: 19760475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine-induced neurotoxicity disrupts pharmacologically evoked dopamine transients in the dorsomedial and dorsolateral striatum.
    Robinson JD; Howard CD; Pastuzyn ED; Byers DL; Keefe KA; Garris PA
    Neurotox Res; 2014 Aug; 26(2):152-67. PubMed ID: 24562969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.